Overview
Adenylosuccinate synthetase-like 1-related distal myopathy, sometimes called ADSSL1 myopathy, is a rare inherited muscle disease caused by changes (mutations) in the ADSSL1 gene. This gene provides instructions for making an enzyme that plays an important role in energy production inside muscle cells. When this enzyme does not work properly, muscle cells — especially those in the hands, feet, and lower legs — gradually weaken and waste away over time. This type of muscle disease is called a 'distal myopathy' because it mainly affects the muscles farthest from the center of the body. People with this condition typically notice weakness and wasting in the muscles of the hands and lower legs, which can make everyday tasks like gripping objects, walking, or climbing stairs increasingly difficult. The disease usually begins in young adulthood, though the age of first symptoms can vary. Some people also experience muscle pain or cramping. The heart and breathing muscles are generally not affected in most reported cases, which is reassuring. There is currently no cure for ADSSL1 myopathy. Treatment focuses on managing symptoms and maintaining quality of life. Physical therapy, occupational therapy, and assistive devices such as braces or orthotics can help people stay as independent as possible. Regular monitoring by a neuromuscular specialist is important to track how the disease is progressing and to adjust care as needed.
Also known as:
Key symptoms:
Weakness in the hands and fingersWeakness in the lower legs and feetMuscle wasting (shrinking) in the hands and lower legsDifficulty walking or foot drop (difficulty lifting the front of the foot)Trouble with fine hand movements like buttoning clothes or writingMuscle cramps or painReduced grip strengthDifficulty climbing stairsSlowly worsening symptoms over years
Clinical phenotype terms (37)— hover any for plain English
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for Adenylosuccinate synthetase-like 1-related distal myopathy.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Adenylosuccinate synthetase-like 1-related distal myopathy at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Adenylosuccinate synthetase-like 1-related distal myopathy.
Community
No community posts yet. Be the first to share your experience with Adenylosuccinate synthetase-like 1-related distal myopathy.
Start the conversation →Latest news about Adenylosuccinate synthetase-like 1-related distal myopathy
No recent news articles for Adenylosuccinate synthetase-like 1-related distal myopathy.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What genetic testing do you recommend to confirm my diagnosis, and should my family members be tested?,How quickly do you expect my symptoms to progress, and what signs should I watch for?,What physical or occupational therapy programs do you recommend for someone with my level of weakness?,Are there any clinical trials or research studies I might be eligible to join?,Should I see a cardiologist or pulmonologist to check if those muscles are affected?,What assistive devices or home modifications might help me stay safe and independent?,Are there any patient registries or support groups for people with ADSSL1 myopathy or distal myopathies?
Common questions about Adenylosuccinate synthetase-like 1-related distal myopathy
What is Adenylosuccinate synthetase-like 1-related distal myopathy?
Adenylosuccinate synthetase-like 1-related distal myopathy, sometimes called ADSSL1 myopathy, is a rare inherited muscle disease caused by changes (mutations) in the ADSSL1 gene. This gene provides instructions for making an enzyme that plays an important role in energy production inside muscle cells. When this enzyme does not work properly, muscle cells — especially those in the hands, feet, and lower legs — gradually weaken and waste away over time. This type of muscle disease is called a 'distal myopathy' because it mainly affects the muscles farthest from the center of the body. People wi
How is Adenylosuccinate synthetase-like 1-related distal myopathy inherited?
Adenylosuccinate synthetase-like 1-related distal myopathy follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Adenylosuccinate synthetase-like 1-related distal myopathy typically begin?
Typical onset of Adenylosuccinate synthetase-like 1-related distal myopathy is adult. Age of onset can vary across affected individuals.
Which specialists treat Adenylosuccinate synthetase-like 1-related distal myopathy?
1 specialists and care centers treating Adenylosuccinate synthetase-like 1-related distal myopathy are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.